-
Signature
-
Laura Heiman, Attorney-in-fact
-
Stock symbol
-
MCK
-
Transactions as of
-
Nov 13, 2023
-
Transactions value $
-
-$3,485,252
-
Form type
-
4
-
Date filed
-
11/14/2023, 06:09 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MCK |
Common Stock |
Options Exercise |
$1.1M |
+7.59K |
+17.47% |
$144.43 |
51K |
Nov 13, 2023 |
Direct |
F1 |
| transaction |
MCK |
Common Stock |
Sale |
-$3.57M |
-7.59K |
-14.87% |
$470.00 |
43.4K |
Nov 13, 2023 |
Direct |
F1 |
| transaction |
MCK |
Common Stock |
Options Exercise |
$364K |
+2.93K |
+6.75% |
$123.99 |
46.4K |
Nov 13, 2023 |
Direct |
F1 |
| transaction |
MCK |
Common Stock |
Sale |
-$1.38M |
-2.93K |
-6.32% |
$470.00 |
43.4K |
Nov 13, 2023 |
Direct |
F1 |
| holding |
MCK |
Common Stock |
|
|
|
|
|
214 |
Nov 13, 2023 |
By the McKesson Corporation 401(k) Retirement Savings Plan |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MCK |
Employee Stock Option (Right-to-buy) |
Options Exercise |
$0 |
-7.59K |
-42.86% |
$0.00 |
10.1K |
Nov 13, 2023 |
Common Stock |
7.59K |
$144.43 |
Direct |
F2 |
| transaction |
MCK |
Employee Stock Option (Right-to-buy) |
Options Exercise |
$0 |
-2.93K |
-42.87% |
$0.00 |
3.91K |
Nov 13, 2023 |
Common Stock |
2.93K |
$123.99 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: